Premier Biomedical(OTC) BIEI

Premier Biomedical, Inc. is a research-based company focused on discovering and developing innovative medical products for the treatment of PTSD, cancer, and various other diseases. The company offers a range of pain management products and is actively developing new therapies utilizing hemp oil extracts.

Products and Services

• Hemp oil-based pain relief patches and topical applicators
• Sequential-dialysis technique for treating various life-threatening conditions
• Feldetrex drug candidate for multiple sclerosis and traumatic brain injuries

Growth Outlook

• Recent quarterly revenue reached $58,300, indicating potential market traction
• Development of innovative therapies positions the company for future growth
• Focus on expanding product offerings in the hemp oil sector enhances market opportunities

Financial Highlights

• Trailing twelve-month revenue of $58,300 shows a positive trend
• Gross profit margin stands at 56.6%, reflecting effective cost management
• Operating income for Q2 2026 was $19,011, indicating operational efficiency

Premier Biomedical, Inc. operates within the healthcare sector, specifically in the medical pharmaceuticals industry. The company is headquartered in Jackson Center, Pennsylvania, and has been in operation since 2010. With a focus on innovative treatments, Premier Biomedical is positioned to address significant healthcare challenges, particularly in pain management and serious medical conditions. The recent quarterly performance demonstrates a shift towards generating revenue, which could signal a turning point for the company. The gross profit margin indicates that the company is managing its costs effectively, while the operating income suggests that operational efficiencies are being realized. As the company continues to develop its product offerings, particularly in the hemp oil space, it may attract further interest from investors looking for opportunities in the evolving healthcare landscape.